Testicular cancer in Australia statistics
The following material has been sourced from the Australian Institute of Health and Welfare
Testicular cancer incorporates ICD-10 cancer code C62 (Malignant neoplasm of testis).
Estimated number of new cases of testicular cancer diagnosed in 2021
980 males
Estimated % of all new male cases of cancer diagnosed in 2021
1.2%
Estimated number of deaths from testicular cancer in 2021
33 males
Estimated % of male deaths from cancer in 2021
0.1%
Chance of surviving at least 5 years (2013–2017)
97%
People living with testicular cancer at the end of 2015 (diagnosed in the 5 year period 2012 to 2016)
3,971
New cases
In 2017, there were 891 new cases of testicular cancer diagnosed in Australia. In 2021, it is estimated that 980 new cases of testicular cancer will be diagnosed in Australia. In 2021, it is estimated that a male has a 1 in 184 (or 0.54%) risk of being diagnosed with testicular cancer by the age of 85.
Figure 1. Estimated cancer incidence in Australia among males, 2021
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
- More information about incidence rates for the most common cancers diagnosed can be found on the NCCI website in the ‘Cancer incidence’ section (https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence)
In 2017, the age-standardised incidence rate was 7.5 cases per 100,000 males. In 2021, it is estimated that the age-standardised incidence rate will be 7.7 cases per 100,000 males. The incidence rate for testicular cancer is expected to increase with age, peaking at age group 30–34 years, and then decrease.
Figure 2. Age-standardised incidence rates for testicular cancer, 1982 to 2017
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
The number of new cases of testicular cancer diagnosed increased from 321 in 1982 to 891 in 2017. Over the same period, the age-standardised incidence rate increased from 4.2 cases per 100,000 males in 1982 to 7.5 cases per 100,000 males in 2017.
Deaths
In 2019, there were 31 deaths from testicular cancer in Australia. In 2021, it is estimated that there will be 33 deaths. In 2021, it is estimated that a male had a 1 in 5,064 (or 0.02%) risk of dying from testicular cancer by the age of 85.
Figure 3. Estimated cancer mortality in Australia among males, 2021
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
- More information about mortality rates for the most common causes of cancer death can be found on the NCCI website in the ‘Cancer mortality’ section (https://ncci.canceraustralia.gov.au/outcomes/cancer-mortality/cancer-mortality)
In 2019, the age-standardised mortality rate was 0.2 deaths per 100,000 males. In 2021, it is estimated that the age-standardised mortality rate will remain at 0.2 deaths per 100,000 males. The mortality rate for testicular cancer is expected to be similar across age groups.
Figure 4. Age-standardised mortality rates for testicular cancer, 1982 to 2019
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
The number of deaths from testicular cancer decreased from 34 in 1982 to 31 in 2019. Over the same period, the age-standardised mortality rate decreased from 0.5 deaths per 100,000 males in 1982 to 0.2 deaths per 100,000 males in 2019.
Survival
In 2013–2017, individuals diagnosed with testicular cancer had a 97% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1988–1992 and 2013–2017, five-year relative survival for testicular cancer improved from 95% to 97%.
Figure 5. 5-year relative survival for testicular cancer, 1988–1992 to 2013–2017, by sex
Notes
- Data sourced from AIHW Cancer Data in Australia 2021 web report and supplementary data tables
Prevalence
At the end of 2016, there were 850 males living who had been diagnosed with testicular cancer that year, 3,971 males living who had been diagnosed with testicular cancer in the previous 5 years (from 2012 to 2016) and 17,925 males living who had been diagnosed with testicular cancer in the previous 35 years (from 1982 to 2016).
For more information on cancer data, see the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.